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Abstract: It is known that some strains of Vibrio parahaemolyticus are responsible for 
gastroenteric diseases caused by the ingestion of marine organisms contaminated with 
these bacterial strains. Organic products that show inhibitory activity on the growth of the 
pathogenic V. parahaemolyticus were extracted from a Vibrio native in the north of Chile. 
The inhibitory organic products were isolated by reverse phase chromatography and 
permeation by Sephadex LH20, and were characterized by spectroscopic and spectrometric 
techniques. The results showed that the prevailing active product is oleic acid, which   
was compared with standards by gas chromatography and high-performance liquid 
chromatography (HPLC). These active products might be useful for controlling the 
proliferation of pathogenic clones of V. parahaemolyticus. 
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1. Introduction 
The marine ecosystem covers around 70% of the surface of the planet, and because of its 
biodiversity of macro- and microorganisms it can be thought of as an important source for the 
extraction of bioactive marine natural products (BMNP). These BMNPs have been studied for use in 
the pharmaceutical industry, to obtain antitumoral drugs, antivirals, antifungals, antihelmintics, 
antiinflamatories, analgesics, immunoregulators, and food supplements, among others [1,2]. 
Since the 1960s there has been increasing research on marine natural products [3]. Studies of the 
chemistry and biological activity of organisms like sponges, coelenterates, and echinoderms have 
shown that they contain a large amount and variety of secondary metabolites with chemical structures 
different from those found in land organisms [4]. Since 1990, the bioactive metabolites discovered in 
marine bacteria have increased exponentially [5]. Most of the bioactive agents have been isolated from 
Streptomyces,  Alteromonas/Pseudoalteromonas,  Bacillus,  Vibrio,  Pseudomonas, and Cytophaga 
obtained from seawater, sediments, marine algae, and invertebrates that produce quinones, polyenes, 
macrolides, alkaloids, peptides, and to a smaller extent terpenoids [3]. It has been determined that 
some products obtained from marine bacteria have bioactive effects against other marine bacteria [6,7]. 
In the 1940s research was centered on secondary metabolites (SM), organic compounds that are 
produced when cellular growth stops and are synthesized as mixtures of chemically related 
compounds, with a huge variety of chemical structures, as a consequence of the diversification and 
branching of their biosynthetic routes [8]. The factors that trigger the production of SMs are not well 
known, but they can be produced when some nutrient in the environment is in limited supply, such as 
nitrogen, carbon, or phosphorus, altering the production of primary metabolites, giving rise to enzyme 
inductors that lead to SMs. In the aquaculture industry, the use of antibiotics has been forbidden 
because they have toxic effects on human health, they cause a negative impact on the environment, and 
their frequent use generates metabolic changes in bacteria that creates resistance to them. In aquaculture 
this resistance to antibiotics generates interest in searching for alternative antibiotics, as well as to 
control “vibriosis”, a common disease caused by bacteria in marine cultures around the world, affecting 
the cultivation of mollusks [9], crustaceans [10], and fish [11]. Chile has reported outbreaks of food 
intoxication caused by the presence of Vibrio parahaemolyticus due to the ingestion of raw or 
undercooked mollusks, fish and shrimp. In the last decade, there have been three such major outbreaks 
in Chile (Antofagasta 1998 with 300 cases, Puerto Montt 2004–2007 with more than 7000 cases) [12]. 
Isnansetyo et al. [11] propose the use of strain S2V2 as a biological control alternative, a bacterium 
that showed inhibiting activity against 68% of a total of 28 pathogenic vibrios analyzed, but the 
challenge remains to purify and elucidate the chemical structure of its inhibiting metabolites. Fatty 
acids are nontoxic compounds that show bactericidal effects [13,14] and have been investigated for 
many years [15]. These fatty acids have been incorporated in foods with the purpose of preventing the 
action of human pathogens like Salmonella,  Listeria  and  Staphylococcus [14]. Singh et al. [16] 
isolated a fatty acid from the cyanobacteria Lyngbya majuscula with activity against Candida albicans. 
Parés and Juárez [8] propose that the antibiotic activity of the SMs generated by the bacteria is based 
on their ability to inhibit essential primary metabolic processes.  
The search for new BMNPs with the ability to inhibit the growth of pathogenic bacteria can 
promote the development of new sources of antibiotics compatible with the environment for use in Mar. Drugs 2011, 9  
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marine cultures [17] and in this way solve the problems of bacterial contamination that have large 
economic effects on the extractive industry of marine resources. In this paper we report the extraction 
and purification of an anti-V. parahaemolyticus molecule isolated from a marine Vibrio. 
2. Results  
The environmental strain used in this work was isolated from scallop’s culture system and was 
selected by a strong and stable inhibitory activity against pathogenic bacteria. In this work we reported 
for the first time, the ability of this strain to inhibit the growth of the pathogen V. parahaemolyticus, 
this was evidenced by the method of double layer agar (Dopazo) showing an inhibition halo of 35 mm 
(Figure 1). These inhibition values were reproducible and no significant differences between the 
replicates were observed (P > 0.05). The results of the molecular characterization using the sequencing 
of gene 16s rRNA indicated that the environmental strain corresponded to the genus Vibrio (according 
to the GenBank database), and the closest relative in GenBank resulted Vibrio sp. 52B8 (accession 
number JF346764) with 100% similarity. 
Figure 1. Identification of the inhibitory activity of the environmental strain against the 
human pathogen V. parahaemolyticus by the Dopazo method. The V. parahaemolyticus 
strains was inoculated above the environmental strain together with a second layer of 
semisolid agar. 
 
Data obtained from the experimental growth of the environmental strain and extraction of their 
bioactive products showed that the organic production increased significantly between 96 and 120 h 
compared to 24, 48 and 72 h. The best inhibition effect was recorded when bacteria entered the 
stationary phase (Figure 2). 
Figure 2. Evaluation of the growth and production of antibacterial substance of the 
environmental strain. Bars indicate the size of the inhibition zone (in mm) and the curve 
indicates the bacterial counts in cell/mL. 
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Evaporation of the solvent, after obtaining different fractions of the extract, resulted in a purified 
residue, whose chromatographic and spectroscopic data (IR, MS and 13C and 1H NMR) when 
compared to the database were identified as a monounsaturated fatty acid of long chain called Oleic 
Acid (OA). The total yield of the active organic product (without fractionation) obtained from the 
environmental strain was about 264 mg/80 L of culture.  
3. Discussion 
The results of this work suggest that the environmental strain has similitude (100%) with the strain 
Vibrio sp. 52B8 (according GenBank database). Jorquera et al. [18] also reported activity inhibitory of 
this bacterium against V. anguillarum-VAR,  V. parahaemolyticus, and V. splendidus, identifying   
an aliphatic hydroxyl ether as the inhibiting molecule produced by these pathogenic vibrios.   
The importance of our results is that we obtained a better purification of the inhibitory product and we 
have identified oleic acid as the active product. Also, Jorquera et al. [18] used the same organic solvent 
for its extraction, with the difference that the bioactive substances were obtained only from the 
supernatant of the culture, while in our work we obtained the bioactive substances from the bacteria 
and the culture supernatant.  
The antibacterial action of fatty acids is commonly attributed to long chain unsaturated fatty acids 
like oleic, linoleic, and linolenic, and their mechanism of action is to inhibit fatty acid synthesis [13]. 
Fatty acids are known not to inhibit Gram negative bacteria like Escherichia coli [19], and this great 
difference can be a consequence of the impermeability of the outer membrane of Gram negative 
bacteria, which acts as a barrier against hydrophobic substances [10]. In our work, we isolated OA 
from a bacterial strain of the genus Vibrio, which has the particularity of inhibiting the growth of  
V. parahaemolyticus. The prevalence of this Vibrio in the marine ecosystem of the Bay of Antofagasta 
should be evaluated because it may account for the low occurrence of the pathogenic clone   
V. parahaemolyticus, with only isolated cases since an epidemic outbreak in 1998 [20], so these 
metabolites may be helping, together with other abiotic factors, to control this pathogen. Even though 
the relation between the structure and the antimicrobial activity of OA is not clear, it seems that the 
number and position of the double bonds, together with having a hydrophilic head and a hydrophobic 
tail may influence the antimicrobial activity, affecting the bipolar membrane of the bacterial cell wall. 
OA is known to have bactericidal activity against important pathogenic microorganisms [21,22], 
including Staphylococcus aureus [23], Helicobacter pylori [22], and Mycobacteria [21], and it has 
been suggested that it provides numerous benefits to human health because its moderate use can lower 
cholesterol levels and reduce atherosclerosis [24]. It further participates in the synthesis of membrane 
phospholipids and contributes to cell membrane physiology in mechanisms, such as signal 
transduction and cellular proliferation [25]. Lunde et al. [26] suggest that the antibacterial effect of 
oleic acids can be related to its ability to penetrate through the cell membranes of bacteria and fungi, 
causing their death by altering the normal function of the cell membrane. Huang et al. [27]   
reported for the first time, extensive antibacterial activity of oleic acids against oral microorganisms,  
including  Streptococcus mutans,  Aggregatibacter actinomycetemcomitans,  Candida albicans,  
Porphyromonas gingivalis,  Fusobacterium nucleatum, and Streptococcus gordonii, suggesting that 
more studies are needed to show that oleic acids can be used as complementary biomolecules to be Mar. Drugs 2011, 9  
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incorporated in humans through various vectors to attack oral infections, caries, and/or periodontal 
disease in situ, using different methods like chewing gum, toothpaste, juices, and milk.   
Cardoso et al. [28] propose that oleic acid modulates wound inflammation and increases the in vivo 
repair response in skin lesions, and they suggest that it can be used as treatment for skin injuries, 
especially for burns, diabetes, or ulcers.  
4. Experimental Section 
4.1. Origin of Bacterial Strains 
The study dealt with the isolated pathogenic bacteria Vibrio parahaemolyticus strain PM48.5 [17] 
and the environmental strain [29] obtained from the strain collection of the Laboratorio de Ecología 
Microbiana of the Universidad de Antofagasta. The bacteria were kept in a strain collection in 
Tryptone Soy Agar culture medium (TSA Oxoid Ltd., Basingstoke, Hampshire, England) under axenic 
conditions at 20 ± 1 °C and frozen in cryobeads.  
4.2. Molecular Characterization of the Environmental Strain 
The genomic DNA of the environmental strain was extracted using the method described by [30]. 
Then gene 16s rRNA was amplified by PCR, using universal primers, performing a first amplification 
with primers 27F and 1542R previously described by [31]. Three processes were then performed for 
sequencing completely the 16s rRNA using the primer 358F, 907 R and the 1492R. The PCR product 
was purified with the purification kit (UltraClean™15 DNA, MoBio Laboratories, CA, USA) 
according to the manufacturer’s instructions, and its DNA was sequenced (Macrogen Inc., Korea). The 
alignments were made with Clustal W [32] on the Bioedit program and the sequence was compared 
with those that were available in the GenBank database.  
4.3. Inhibition Tests 
The inhibition tests were carried out by the “double layer” method [33], inoculating 10 µL   
(7.1 × 10
5 cells/mL) of the environmental strain from an overnight culture in the center of a Petri dish 
with Müller Hinton medium (Difco), incubating at 20 °C for 48 h. After that time the macro colony 
formed was exposed to chloroform vapors for 45 min, then a second layer of semisolid agar previously 
inoculated with the pathogenic bacteria V. parahaemolyticus (2.3 × 10
4 cells/mL) was added and it was 
incubated at 20 °C for 48 h. The presence of a well defined inhibition halo around the macro colony 
was considered as antibacterial activity. The study was made in triplicate and the degree of inhibition 
was determined measuring the diameter of the halo, considering values greater than 5 mm as strong 
inhibition according to [34]. 
4.4. Growth of the Environmental Strain and Extraction of Its Bioactive Products 
The environmental strain was inoculated in minimum medium M9 [35] at the initial concentration 
of 1 × 10
7 cells/mL at 20 °C. Bacteria abundances (cells mL
−1) were counted after of 6, 12, 24, 30,  
36, 48, 54, 60, 72, 78, 90, 96, 102, 108, and 120 h, staining the bacteria with fluorochrome   Mar. Drugs 2011, 9  
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4′,6-diamino-2-phenylindol (DAPI) [36] and observing under an epifluorescence microscope at   
100× (Olympus BN-2) equipped with a DM400 dichroic mirror and UG1 excitation and L420 
absorption filters. In parallel, the organic products were extracted after 24, 48, 72, 96, and 120 h of 
cultivation, adding 150 mL of the ethyl acetate per liter of culture (bacteria + supernatant). The organic 
phase was recovered and it was left for 20 min over anhydrous sodium sulfate (Merck, Germany), 
filtered through filter paper, concentrated to dryness in a rotavapor at 45 °C, and lyophilized for 24 h 
to remove the moisture. The initial sample or extract was kept at −20 °C until its use. Every hour of 
sampling bioassays were carried out by the diffusion filter method adding 2 mg/product filter. The 
pathogenic V. parahaemolyticus was previously laid in extended a concentration of (1 × 10
5 cells/mL). 
The plates were incubated for 48 h at 20 °C. 
4.5. Purification and Characterization of the Oleic Acid 
The environmental strain was cultivated in 80 L of M9 minimum liquid medium for 96 h at   
an initial concentration of 1 × 10
7 cells/mL at 20 °C, and the same extraction method mentioned under 
point 4.4 was used. The ethyl acetate extract (350 mg) was separated depending on their polarity by 
means of reverse phase chromatography (RPC) in a chromatographic column compacted with silica 
gel (100 C18-Reversed phase) to a height of 10 cm. The extract was added to the column adsorbed on 
the same silica gel used in the column. The mobile phase was distilled water (100 mL) as an initial 
fraction, then mixtures (100 mL) of distilled water and methanol in 3:1, 3:2, 2:3 and 1:4 ratios, and 
finally 100 mL of the solvents methanol, dichloromethane, and methanol. From this procedure were 
obtained 8 fractions: 1 (16.9 mg), 2 (1.6 mg), 3 (14.4 mg), 4 (37.5 mg), 5 (21.9 mg), 6 (120.6 mg),  
7 (37.7 mg) and 8 (12.8 mg) them dried in a rotavapor at 45 °C and lyophilized for 24 h. From these 
fractions the number 6 showed inhibitory activity against V. parahaemolyticus and them this fraction 
was eluted in methanol 100% and added to a column using Sephadex LH-20 (Pharmacia Fine 
Chemicals ref. 17-090-01), and a hexane/dichloromethane/methanol mixture in a 3:1:1 mobile phase. 
From this procedure were obtained 8 fractions: 1 (9.7 mg), 2 (6.2 mg), 3 (76.9 mg), 4 (11.6 mg),  
5 (5 mg), 6 (2.2 mg), 7 (3.8 mg) and 8 (5.4 mg) were dried in a rotavapor at 45 °C and lyophilized for  
24 h. The active fraction 3 (76.9 mg) pure enough (98%) was unambiguously identified as oleic acid, 
by comparing their mass spectra and 
1H and 
13C NMR to those of authentic compound. 
4.6. Statistical Analysis 
The experiments were designed to evaluate the effects of the antibacterial products from the 
environmental strain on the growth of V. parahaemolyticus. Before ANOVA, the data were evaluated 
in terms of their fulfillment of the assumptions of variance homogeneity (Bartlett’s test), normal data 
distribution (Kolmogorov-Smirnov test), normality of the residuals (Anderson-Darling test), 
independence and linearity of the model using the MINITAB 14 statistical software. The data were 
then analyzed with one-way ANOVA [37].  Mar. Drugs 2011, 9  
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5. Conclusions 
In this study, the isolation of an environmental strain belonging to the genus Vibrio, with 
antibacterial effect of V. parahaemolyticus growth, was reported. This could have profound ecological 
implications in the aquatic ecosystems. The oleic acid produced by this Vibrio strain could be useful as 
a biocontrol against V. parahaemolyticus and might represent a contribution not only in the 
aquaculture industry, but also at the clinical level. However, optimizing the production of the active 
organic product of this bacterial strain is a challenge that must be considered in order to use this 
compound to contrast the pathogenic action of V. parahaemolyticus. 
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